is doing DD
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Very nice news out today! OTC still needs to be updated.
This is getting ready to explode.
http://empireoilrefineriescorp.com/
Nice slaps!
It's not far now at 1.92$.
The Big Event is coming soon, 9m on bid 1,6m on ask.
Look at those slaps! 2k slap at 1.94, very nice.
ORRV?
https://www.mccuskerco.com/
go to "investors" then "PR" and it brings you to:
https://www.otcmarkets.com/stock/ORRV/news
??
$MHHC Supplemental Information - MOU
https://backend.otcmarkets.com/otcapi/company/financial-report/197500/content
Big news out.
headline could've been nicer.
A. DESCRIPTION OF ISSUER’S BUSINESS OPERATIONS.
The Company is engaged in the development and testing of various alternative and exotic
energy products for eventual marketing to the general public through a manufacturing
partner or licensee. The Company currently is manufacturing and/or testing various unique
battery charging products for which it has applied for patent protection. The Company
expects to eventually manufacture (either internally or through a partner) and market these
battery products and achieve profitability by application of the Company’s management
and/or resource expertise.
We will be updating our website for a new and exciting announcement to be out shortly
8:37 AM - 9 Jul 2018
We will be updating our website for a new and exciting announcement to be out shortly
— SuntexenterprisesSNTX (@SuntexSNTX) July 9, 2018
Nice slaps going on here.
big slaps again today.
A bison, an eagle and a turkey walk into a bar located in a galaxy far far away and they need a lyfe for their meta projects which would be......... building roads on the moon who look a bit umen?
I guess the punch line would be more easy to find if we knew which animal spoke first?
Maybe the bison is happy about its new status?
Maybe the eagle is sad about it?
Maybe the turkey hopes it will be pardoned?
Either way, original television seems highly entertaining.
http://spacebison.com/
Thanks, I simply copy pasted what I linked and felt I didn't need to add anything else.
The parties intend to complete the purchase no later than July 31, 2018.
Looking at 30min chart and 50MA I'm sure some would say the bulls are in full control right now.
Break 008 resistance and explosion is ready imho.
Power hour will be very interesting.
$EORZ 0065-0069$
0065s are gone!
45m float, half of it traded in 4days, PPS 0065, this has amazing potential!
EORZ: half the float traded in 4 days 006-0065$
Missing runners happens but I am not missing this one.
Strong hands here.
I'm very happy I found this gem before filings hit.
$EORZ 005-0058 huge vol.
https://www.tradingview.com/chart/?symbol=OTC:EORZ
Big slaps coming in.
Half the float traded in 4 days? nice!
More than double the previous vol record. https://www.tradingview.com/chart/?symbol=OTC:EORZ
Monthly chart shows record volume for this month, by far, and we're only the 13!
Very nice action today here.
You can eat whenever you want to eat, it's just nice to have a table for whoever wants to eat whatever whenever?
Yes and thanks for reminding me about this merger.
I wanted to mention the 13m vol. in 3 days earlier. That's a considerable chunk of the float and very few transactions afterwards.
It's not a dead ticker it's just waiting for news of who will merge in and you linked the old website so I felt like like I was in a treasure hunt... so thank you very much!
I like treasure hunts.
I feel very confident my investment will become very fruitful very quickly.
New CEO was with Pfizer for 8 years. If that's not something to trust then I don't know what is.
You're hallucinating words! Changing a CEO can be very positive for a company, look at the chart.
Dr. Urbanski spent eight years with Pfizer Inc. (NYSE:PFE), or Pfizer, and held several positions with Pfizer, including Vice President and Chief Medical Officer of the Established Products Business Unit, Senior Medical Director of Oncology Clinical R&D, Senior Medical Director of Breast Cancer Products and Medical Director of Diversified Products. He brings extensive experience in developing and overseeing clinical studies, including Phase 3b and Phase 4 studies
Shawn Cross:
https://www.linkedin.com/in/shawn-cross-b06a7310/
So it seems GTBP decided to hire someone with a medical background instead of financial/business/banking background.
It's a choice. And reading Dr. Urbanski's impressive CV AND the chart it looks very positive.
I never heard of SEC suspending for CEO change.
The way you wrote it sounded like it was written in an edgar filing.
https://www.prnewswire.com/news-releases/gt-biopharma-gtbp-otcqb-announces-appointment-of-shawn-m-cross-as-chairman-and-chief-executive-officer-674156703.html
Charts don't lie they say?
News about Shawn Cross becoming new CEO was Feb.15 2018, pps was 1.995 at the open and had a slow and steady decline until June. I guess rumors of CEO change made the PPS go higher in June. and since Dr Urbanski has been officially appointed new CEO pps went from 1.43 to 1.73. And that's since the 5th of July.
Perhaps his impressive CV has something to do with it?
The word "ABRUPTLY" is not in the edgar filing.
ctrl+f = magic
Dr. Urbanski spent eight years with Pfizer Inc. (NYSE:PFE), or Pfizer, and held several positions with Pfizer, including Vice President and Chief Medical Officer of the Established Products Business Unit, Senior Medical Director of Oncology Clinical R&D, Senior Medical Director of Breast Cancer Products and Medical Director of Diversified Products. He brings extensive experience in developing and overseeing clinical studies, including Phase 3b and Phase 4 studies
On July 3, 2018, the Board appointed Dr. Raymond Urbanski as the Chief Executive Officer of the Company and the Chairman of the Board and Dr. John N. Bonfiglio as a member of the Board.
Dr. Urbanski, age 58, has been the Company’s President since May 2018, and has been the Company’s Chief Medical Officer since September 2017. Before joining the Company, he was the Chief Medical Officer for MannKind Corporation (NASDAQ:MNKD) from August 2015 to September 2017. He was the Chief Medical Officer for Mylan Inc. (NASDAQ:MYL) from August 2012 to September 2014. Dr. Urbanski spent eight years with Pfizer Inc. (NYSE:PFE), or Pfizer, and held several positions with Pfizer, including Vice President and Chief Medical Officer of the Established Products Business Unit, Senior Medical Director of Oncology Clinical R&D, Senior Medical Director of Breast Cancer Products and Medical Director of Diversified Products. He brings extensive experience in developing and overseeing clinical studies, including Phase 3b and Phase 4 studies (including line extensions) for sunitinib (Sutent), exemestane (Aromasin), irinotecan (Camptosar), epirubicin (Ellence), axitinib, IGF1R inhibitor, and tremilimumab. In addition to his role with Pfizer, Dr. Urbanski has also served as Chief Medical Officer of Metabolex Inc. from October 2011 to June 2012, and senior director of U.S. Medical Affairs for Aventis (NYSE:SNY). Dr. Ubanski received his Ph.D, and M.D. from the University of Medicine and Dentistry of New Jersey – New Jersey Medical School.
Before joining the Company, Dr. Bonfiglio, was a consultant to TapImmune Corporation (NASDAQ:TPIV) from February 2015 to July 2016, and later served as TapImmune Corporation’s President and Chief Operating Officer from July 2016 to April 2017. He was the President and Chief Executive Officer of Oragenics (NYSEAMERICAN:OGEN) from May 2011 to November 2014. He brings extensive business management and strategic growth experience, with a focus on the biopharmaceutical drug industry. Dr. Bonfiglio previously served on the boards of directors of TapImmune Corporation and Microlin Therapeutics. Dr. Bonfiglio received his Ph.D. from the University of California at San Diego and his M.B.A. from Pepperdine University.